Q&A: Dittmer Explains How CORVASEQ Surveillance Program Detects Variants like Omicron
Dirk Dittmer, PhD, explains how UNC-led CORVASEQ program helps to track the spread and development of variants like Omicron in North Carolina.
NC Child Hunger Leaders Conference Set for February 2022
The NC Child Hunger Leaders Conference will return for its 11th annual event on Thursday, Feb. 17, 2022.
Announcements, Covid-19 / Coronavirus, News, Nutrition, Pediatrics And Children's Health, Vital Signs
Reminder: Eshelman Institute Grant Funding Available
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious…
Allied Health Sciences, Announcements, Awards, Rankings and Recognitions, Bioinformatics, Cancer, Clinical Research, Covid-19 / Coronavirus, Diversity, Equity and Inclusion, Education, Events, Faculty, General Medicine, Global Health, Infectious Diseases, Neurology, News, North Carolina, Oncology, Physical Medicine & Rehabilitation, Physical Therapy, Pulmonology, Research, School of Medicine, Technology and Innovation, UNC Health, Vital Signs, Wellness
UNC-Led CORVASEQ Surveillance Program Detects Omicron Variant in North Carolina
The Coronavirus Variant Sequencing (CORVASEQ) Surveillance Program, led by a team of UNC researchers, has detected the Omicron SARS-CoV-2 variant in North Carolina. Together, members of the program at UNC-Chapel…
Covid-19 / Coronavirus, News, Research, School of Medicine, UNC Health, Vital Signs
Mieses Malchuk Shares the Importance of Getting Vaccinated While Pregnant
COVID-19 vaccines are safe and effective for pregnant people and their developing baby. Hear expert advice from Alexa Mieses Malchuk, MD, about staying protected.
UNC Health Hosts Media Briefing on Omicron Variant
On Wednesday, UNC Health experts David Wohl, and Melissa Miller met with the media to answer questions and offer their expertise regarding what we know so far about the Omicron…
Covid-19 / Coronavirus, News, Research, School of Medicine, UNC Health, Vital Signs
DCRI, UNC CHER, and Partners Launch Free Testing Project to Slow the Spread of COVID-19
The Duke Clinical Research Institute (DCRI), Center for Health Equity Research at UNC-Chapel Hill (UNC-CHER), and Community-Campus Partnerships for Health (CCPH) today announced plans to deliver their You & Me…
Covid-19 / Coronavirus, Infection Prevention, Infectious Diseases, News, Social Medicine, Vital Signs
Corbie-Smith Co-Authors Opinion on Data Inclusivity
Giselle Corbie, CHER Director, has co-authored an opinion piece for STAT with Warren Kibbe of the Duke Cancer Institute, calling for engaging communities “around how and why data affect them.”
InsideTraCS with Emily Pfaff, PhD
Emily Pfaff, PhD, is Co-director of Informatics and Data Science at NC TraCS. She has a PhD in Health Informatics and a master’s in Information Science, both from UNC. Her…
Covid-19 / Coronavirus, Faculty, Infectious Diseases, Vital Signs
Phase 3 Data Show Monoclonal Antibodies Provide long-term Protection Against COVID-19
A single dose of REGEN-COV, a combination monoclonal antibody therapy, reduced the risk of COVID-19 by 81.6% several months after a single dose. UNC School of Medicine’s Myron Cohen, MD,…
UNC Rex Cardiologist Takes Kids To Get Vaccinated
UNC Rex Cardiologist Christopher Kelly, MS, MD, RPVI, CBCCT, takes his children to get vaccinated at UNC Family Medicine at Panther Creek in Cary.
Covid-19 / Coronavirus, Infection Prevention, News, Vital Signs
Gracie Howell, Moderna COVID-19 Vaccine Clinical Trial Participant, Returns to Receive Booster Shot
Gracie Howell, Moderna COVID-19 vaccine clinical trial participant, continues her journey. Hear her story as she returns nine months later to receive her booster shot and why she values participating…
Clinical Research, Covid-19 / Coronavirus, Infectious Diseases, News, Research
Carolina Research Leads to Effective Experimental Pill to Treat COVID-19
University of North Carolina at Chapel Hill research set the stage to seek emergency authorization of the first oral antiviral drug to treat COVID-19, a pill developed by the pharmaceutical…
Formulary Restriction – Ivermectin for COVID-19
The System Anti-Infective P&T Subcommittee has approved a formulary restriction for ivermectin (Stromectol). As of Sept. 21, 2021, ivermectin is RESTRICTED to FDA-approved indications only.
Call to Action from Pediatric Leaders across the Triangle
Clinical leaders of Children’s hospitals in the North Carolina Triangle region, have shared a joint letter to advance and protect child health. Hospitalizations of children due to COVID have increased…
Experimental Monoclonal Antibody Combo Shows Significant Efficacy against COVID-19
As part of the NIH-sponsored ACTIV-2 clinical trial for COVID-19 outpatients, preliminary data revealed that a new combination monoclonal antibody treatment reduced hospitalizations and death by 78 percent in high-risk…
Clarifications on Vaccine Requirements and COVID-19 Precautions for SOM Employees
Many of you have asked questions about the current state of vaccine distribution and the COVID-19 precautions are currently in effect. To help clarify, the following table has been created…
Dr. Anita Skariah Shares Her Perspective About Getting Vaccinated
Dr. Anita Skariah, DO, Medical Director of Orange Family Medical Group, shares her perspective about getting vaccinated and why it’s important to protect yourself against the Delta variant.
Wesley Burks Addresses the UNC Health / UNC School of Medicine Community on COVID-19
In this video, Dr. Burks, Dean of the UNC School of Medicine and CEO of UNC Health, thanks teammates taking care of our patients and addresses the state of the pandemic and importance of…
All SOM Teammates Working at UNC Health Sites Required to Verify Vaccination Status or Request an Exemption
School of Medicine teammates that work in a clinical environment must provide verification of vaccination using the UNC EHS Vaccine Certification Portal or have received a medical or religious exemption…
